Company Filing History:
11 out of 340 
5 out of 6,662 
1 out of 7 Years Active: 1987-1993
Title: Innovations and Contributions of Hans P. Kraemer
Introduction
Hans P. Kraemer is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on anthracycline derivatives and cis-platinum complexes. With a total of 16 patents to his name, Kraemer's inventions have the potential to impact cancer treatment and other medical applications.
Latest Patents
One of Kraemer's latest patents involves anthracycline derivatives that exhibit cytostatic activity. This invention relates to new compounds characterized by a specific general formula, which can exist in the form of acid addition salts of physiologically acceptable inorganic or organic acids. The compounds include various substituents that enhance their therapeutic potential. Another significant patent focuses on cis-platinum complexes, detailing a process for their preparation and potential applications in pharmaceuticals.
Career Highlights
Throughout his career, Hans P. Kraemer has worked with prominent companies in the pharmaceutical industry, including Behringwerke Aktiengesellschaft and Hoechst Aktiengesellschaft. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
Kraemer has collaborated with notable colleagues, including Cenek Kolar and Hans G. Berscheid. These partnerships have fostered a collaborative environment that has led to the development of groundbreaking inventions in the pharmaceutical field.
Conclusion
Hans P. Kraemer's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new treatments, showcasing the importance of innovation in medicine.